Off-the-shelf immunotherapy targets kidney cancer
UCLA Health - 29-Aug-2025Engineered NKT cells attack tumours and reshape defences, offering new hope for kidney cancer
Join the club for FREE to access the whole archive and other member benefits.
Engineered NKT cells attack tumours and reshape defences, offering new hope for kidney cancer
New RNA method may cut costs and simplify cancer treatment by skipping lab-grown cell steps
AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
DNase I improved CAR T cell impact and survival in a melanoma model
CAR T cells are modified to produce interleukin-10, a molecule defeating various cancers
No resources found!
No blog posts found!